Skip to main content

Table 2 Management during hospitalization in tertiary and secondary care hospitals in Estonia in 2001 and 2007

From: Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007

 

Tertiary care hospitals

 

Secondary care hospitals

 
 

Year 2001

Year 2007

P

Year 2001

Year 2007

P

 

%

%

 

%

%

 
 

n = 210

n = 327

 

n = 213

n = 360

 

Medications

      

   Aspirin

87.1

94.2

0.004

88.3

86.4

0.428

   Clopidogrel/ticlopidine

17.1

61.5

< 0.001

0.0

10.6

NA

   Anticoagulants

89.0

93.0

0.092

85.4

92.8

0.007

   Glycoprotein IIb/IIIa inh

12.4

38.8

< 0.001

0.5

3.1

0.037

   Beta-blockers

79.5

82.6

0.395

76.1

77.8

0.707

   Nitrates

92.4

78.9

< 0.001

96.7

85.6

< 0.001

   ACEI/ARB

70.5

74.9

0.267

37.1

62.2

< 0.001

   Statins

26.7

67.9

< 0.001

5.6

30.8

< 0.001

Cardiac catheterization

35.7

78.3

< 0.001

0.0

6.7

NA

Revascularisation

27.6

64.2

< 0.001

0.0

4.2

NA

   PCI

22.4

61.5

< 0.001

0.0

4.2

NA

   CABG

5.2

3.7

0.381

0.0

0.0

NA

Reperfusion for STEMI

42.3

64.2

< 0.001

44.1

34.1

0.073

   Thrombolysis

35.4

7.4

< 0.001

44.1

34.1

0.073

   Primary PCI

6.9

56.8

< 0.001

0.0

0.0

NA

Echocardiography

81.9

85.3

0.292

52.1

51.9

0.969

Stress-testing

19.0

1.8

< 0.001

8.0

2.6

0.023

  1. ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; CABG, coronary artery bypass grafting; NA, not applicable; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction